Drugs / UTENPANIUM
last change Oct 2023 re-read 9 days ago

UTENPANIUM

Small molecule

Developed for
obesity disorder · adiposis dolorosa · Lipedema
Investigated by
Raziel Therapeutics Ltd. · Spaulding Clinical Research LLC

Trials 4

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/22 trials
Phase 1/2 NCT05476679 Sep 2022 → Jun 2023 — Raziel Therapeutics Ltd. Completed No outcome recorded
Phase 1/2 NCT05466448 Jul 2022 → May 2023 — Raziel Therapeutics Ltd. Completed No outcome recorded
Phase 22 trials
Phase 2 NCT05763160 May → Jul 2023 — Raziel Therapeutics Ltd. Completed No outcome recorded
Phase 2 NCT03171415 Jul 2017 → Dec 2018 obesity disorder Raziel Therapeutics Ltd. Completed No outcome recorded
Comparator or background therapy5 trials
Phase 2 NCT05445557 Comparator Mar → Oct 2022 — Raziel Therapeutics Ltd. Completed No outcome recorded
Phase 2 NCT04867434 Comparator Jun 2021 → Apr 2022 — Raziel Therapeutics Ltd. Completed No outcome recorded
Phase 2 NCT04229030 Comparator Jul 2020 → Feb 2021 adiposis dolorosa Raziel Therapeutics Ltd. Completed No outcome recorded
Phase 2 NCT04086823 Comparator Feb → Sep 2020 — Raziel Therapeutics Ltd. Completed No outcome recorded
Phase 2 NCT03492840 Comparator Jun 2018 → May 2019 Lipedema, adiposis dolorosa Raziel Therapeutics Ltd. Completed No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 10 sources stand behind the page.

FieldValueCited text
Known as UTENPANIUM ChEMBL registry synonym — accepted as the source's own label CHEMBL5316162 ↗
Known as RZL-012 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04086823 ↗
8

NCT03492840 ↗

NCT04867434 ↗

NCT05466448 ↗

NCT05476679 ↗

NCT04229030 ↗

NCT05763160 ↗

NCT05445557 ↗

NCT03171415 ↗

Known as RZL-012 CATION ChEMBL registry synonym — accepted as the source's own label CHEMBL5316162 ↗
Known as UTENPANIUM CHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL5316162 ↗
Modality Small molecule “small synthetic molecule for the treatment of Dercum's Disease lipomas” NCT04229030 ↗
Route Subcutaneous “into the abdominal subcutaneous fat” NCT03171415 ↗